Share on Pinterest Transient ischemic attacks may result in 1 year of chronic fatigue, a new study finds. Image credit: Westend61/Getty Images. Transient ischemic attacks occur when there is a ...

Bayer BAYRY announced that the FDA has accepted its new drug application (NDA) for its investigational, once-daily, oral ...

A transient ischemic attack, also known as a mini-stroke, is typically defined as a temporary blockage of blood flow to the brain that causes symptoms that go away within a day, but a new study finds ...

Asundexian plus antiplatelet therapy reduces IS risk in patients with noncardioembolic stroke or high-risk transient ischemic attack.

Transient ischaemic attack (TIA) represents a brief episode of neurological dysfunction caused by focal cortical or retinal ischaemia without acute infarction. Globally, the annual incidence of TIA ...

Prolonged fatigue could indicate poor sleep habits — but it could also be a lingering effect of mini-strokes. That’s according to a new study from Aalborg University Hospital in Denmark, which was ...

Bayer today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s New Drug Application (NDA) ...

Accurate diagnosis of transient ischemic attacks (TIAs) is challenging. This study was aimed at analyzing blood biomarkers to distinguish TIAs from mimics. The levels of eight candidate biomarkers ...

In the phase 3 OCEANIC-STROKE trial, asundexian significantly reduced recurrent ischemic stroke risk compared with placebo without significantly increasing major bleeding. The Food and Drug ...